Literature DB >> 12978288

Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.

M TOOHEY.   

Abstract

Entities:  

Keywords:  COUMARIN/derivatives; PHENYLINDANEDIONE/toxicity; PROTHROMBIN; VITAMIN K/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 12978288      PMCID： PMC2021558          DOI： 10.1136/bmj.2.4786.687

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  The effect of vitamin K administered orally on the control of the coagulation defect induced by dicumarol.

Authors:  B F FULLER; N W BARKER
Journal:  Minn Med       Date:  1951-04

2.  Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.

Authors:  R S OVERMAN; C W SORENSON; I S WRIGHT
Journal:  J Am Med Assoc       Date:  1951-02-10

3.  Antagonism of dicumarol by vitamin K preparations.

Authors:  R MILLER; W P HARVEY; C A FINCH
Journal:  N Engl J Med       Date:  1950-02-09       Impact factor: 91.245
  3 in total
  6 in total

1.  Effect of intravenous vitamin K1 on the action of phenindione.

Authors:  P DAWSON
Journal:  Br Med J       Date:  1955-12-10

2.  Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.

Authors:  A ENGLISH; S R TOWNSEND; D G CAMERON
Journal:  Can Med Assoc J       Date:  1955-02-01       Impact factor: 8.262

3.  Vitamin K in anticoagulant therapy.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1954-05-01

4.  [Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].

Authors:  S WITTE; P DIRNBERGER
Journal:  Klin Wochenschr       Date:  1953-09-01

5.  Clinical trial of phenylindanedione as an anticoagulant.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1953-03-21

6.  Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.

Authors:  J N CHALMERS; M F DIXON; W POLACK
Journal:  Br Med J       Date:  1954-10-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.